SCHEMBL30962911

SCHEMBL30962911

COc1nc(Nc2ccc(C3CCN(C)CC3)c(C)c2)nc(-c2ccccc2Cl)c1C(N)=O

nearest known ligand 0.48

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ WEE1 P30291 3/20 0.48
▸ ALK Q9UM73 4/20 0.43
▸ MET P08581 1/20 0.42
▸ AXL P30530 1/20 0.42
▸ MERTK Q12866 1/20 0.42
▸ EHMT2 Q96KQ7 1/20 0.41
▸ TNK2 Q07912 3/20 0.40
▸ MAP4K1 Q92918 1/20 0.39
▸ EGFR P00533 4/20 0.38
▸ CCNT1 O60563 1/20 0.37
▸ CDK4 P11802 1/20 0.37
▸ CCND1 P24385 1/20 0.37
▸ CDK9 P50750 1/20 0.37
▸ CDK6 Q00534 1/20 0.37
▸ CDK11A Q9UQ88 1/20 0.37
▸ KCNH2 Q12809 1/20 0.37
▸ FLT4 P35916 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30962797 0.92 WEE1 (0.47) WEE1ALKMETAXLMERTK
SCHEMBL30962777 0.91 WEE1 (0.46) WEE1ALKMETAXLMERTK
SCHEMBL30962764 0.91 WEE1 (0.45) WEE1ALKEHMT2TNK2MAP4K1
SCHEMBL30962873 0.91 WEE1 (0.43) WEE1ALKMETAXLMERTK
SCHEMBL30962698 0.91 ALK (0.43) WEE1ALKEHMT2TNK2MAP4K1
SCHEMBL30962861 0.90 ALK (0.41) WEE1ALKMETAXLMERTK
SCHEMBL30962727 0.89 ALK (0.45) WEE1ALKEHMT2TNK2MAP4K1
SCHEMBL30962847 0.88 TBK1 (0.42) WEE1ALKEHMT2TNK2MAP4K1
SCHEMBL30962810 0.88 WEE1 (0.44) WEE1ALKEHMT2MAP4K1CCNT1
SCHEMBL30962694 0.88 WEE1 (0.44) WEE1ALKMETAXLMERTK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4642767-A1 PYRIMIDINE CARBOXAMIDE COMPOUNDS Acrivon Therapeutics, Inc. (US) 2025-11-05 — — EP disclosed
WO-2024145505-A1 PYRIMIDINE CARBOXAMIDE COMPOUNDS ACRIVON THERAPEUTICS, INC. (US) 2024-07-04 — — WO disclosed
Send feedback